SEAN P LEE
Physician at Bunkerhill St, Pittsburgh, PA

License number
Florida 20060
Issued Date
May 9, 2014
Effective Date
May 9, 2014
Expiration Date
Jun 30, 2016
Category
Health Care
Type
Registration for Resident/HSE Physician
Address
Address 2
5700 Bunkerhill St APT 1105, Pittsburgh, PA 15206
1600 SW Archer Rd BOX 100254, Gainesville, FL 32610
Phone
(626) 290-8999

Professional information

Sean Lee Photo 1

Bioactive Glass Treatment Of Inflammation In Skin Conditions

US Patent:
6423343, Jul 23, 2002
Filed:
Jan 23, 1998
Appl. No.:
09/012272
Inventors:
Sean Lee - Gainesville FL
James L. Meyers - Gainesville FL
Assignee:
USBiomaterials Corporation - Alachua FL
International Classification:
A61K 914
US Classification:
424489, 424401, 424601, 424602, 424606, 424657, 424660, 424675, 424688, 424692, 424722, 424724, 424400, 424405, 424484, 514830, 514859, 514861, 514862, 514863, 514864, 514886, 514887, 514951
Abstract:
This invention relates to a method for treating inflammatory symptoms such as burning, redness, itching, swelling and pain which accompany skin disorders other than wounds of the skin. The method comprising topical application of a topical medicinal composition comprising a non-interlinked, particulate bioactive glass mixed with a topical medicinal carrier to the site of the skin disorder.


Sean P Lee Photo 2

Dr. Sean P Lee, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
Emergency Medicine
Address:
4401 Penn Ave, Pittsburgh 15224
(412) 692-5325 (Phone)
TRIANGLE RADIATION ONCOLOGY
1400 Locust St, Pittsburgh 15219
(412) 232-7475 (Phone), (412) 232-8002 (Fax)
230 Mckee Pl STE 500, Pittsburgh 15213
UNIVERSITY PITTSBURGH PHYS
200 Lothrop St STE 9055, Pittsburgh 15213
(412) 648-9623 (Phone), (412) 647-8060 (Fax)
CENTER FOR EMERGENCY MEDICINE
230 Mckee Pl STE 500, Pittsburgh 15213
(412) 647-8287 (Phone), (412) 647-1111 (Fax)
Pittsburgh Office
4401 Penn Ave STE 2000, Pittsburgh 15224
(412) 692-5325 (Phone), (412) 692-6076 (Fax)
Pittsburgh Office
5230 Centre Ave, Pittsburgh 15232
(412) 623-2121 (Phone), (412) 683-2409 (Fax)
Languages:
English
Education:
Medical School
University of Pittsburgh / Main Campus
Graduated: 2011


Sean Lee Photo 3

Anti-Inflammatory Bioactive Glass Particulates

US Patent:
6663878, Dec 16, 2003
Filed:
Apr 28, 2000
Appl. No.:
09/560475
Inventors:
David C. Greenspan - Gainesville FL
Sean Lee - Gainesville FL
Marlo tan Walpole - Gainesville FL
Assignee:
USBIOMATERIALS Corp. - Alachua FL
International Classification:
A61K 914
US Classification:
424422, 424443, 424444, 424 851, 424 852, 424489, 428370, 435 695, 435 691, 435 6951
Abstract:
Compositions and methods for systemically minimizing the inflammatory effects of TNF- are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 m, alone or in combination with anti-inflammatory agents and other therapeutic agents. The compositions can include an appropriate carrier for oral, intramuscular, intraperitoneal or intravenous administration. When administered to a patient, the particles bring about elevated levels of IL-6 and do not cause elevated levels of TNF-.


Sean Lee Photo 4

Student At University Of Pittsburgh

Location:
Greater Pittsburgh Area
Industry:
Mental Health Care
Education:
University of Pittsburgh 2007 - 2011
University of California, Berkeley


Sean Lee Photo 5

Anti-Inflammatory Bioactive Glass Particulates

US Patent:
2004009, May 20, 2004
Filed:
Nov 7, 2003
Appl. No.:
10/703654
Inventors:
David Greenspan - Gainesville FL, US
Sean Lee - Gainesville FL, US
Marlo Walpole - Gainesville FL, US
Assignee:
US BioMaterials Corporation - Alachua FL
International Classification:
A61K009/14, A61K038/18
US Classification:
424/489000, 514/012000
Abstract:
Compositions and methods for systemically minimizing the inflammatory effects of TNF- are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 m, alone or in combination with anti-inflammatory agents and other therapeutic agents. The compositions can include an appropriate carrier for oral, intramuscular, intraperitoneal or intravenous administration. When administered to a patient, the particles bring about elevated levels of IL-6 and do not cause elevated levels of TNF-.